Home › Stomach Cancer
Stomach Cancer clinical trials recruiting in the U.S.
135 studies for Stomach Cancer are recruiting participants at sites across the United States.
Did you know risk factors for stomach (gastric) cancer include a diet high in salty or smoked food or having an H. pylori infection? Learn more here.
Cities with the most studies
- Houston, TX44 studies
- New York City, NY33 studies
- Boston, MA32 studies
- Nashville, TN27 studies
- Los Angeles, CA23 studies
- Arlington, VA21 studies
- Baldwin Park, CA21 studies
- Dallas, TX20 studies
- San Antonio, TX20 studies
- Grand Rapids, MI20 studies
- Chicago, IL19 studies
- St. Louis, MO18 studies
- Washington, DC16 studies
- Detroit, MI15 studies
- Pittsburgh, PA14 studies
- Philadelphia, PA13 studies
- Orange, CA13 studies
- Portland, OR13 studies
- Cleveland, OH12 studies
- Queens, NY12 studies
- Denver, CO11 studies
- Orlando, FL11 studies
- Atlanta, GA11 studies
- Madison, WI11 studies
- Mountain View, CA11 studies
- Durham, NC10 studies
- Oklahoma City, OK10 studies
- Seattle, WA10 studies
- Aurora, CO10 studies
- Edison, NJ10 studies
- Kansas City, MO10 studies
- Austin, TX9 studies
- Charlotte, NC9 studies
- New Haven, CT9 studies
- Omaha, NE9 studies
- San Francisco, CA9 studies
- Irving, TX9 studies
- San Diego, CA9 studies
- Columbus, OH9 studies
- Tampa, FL9 studies
By state
- Alabama6 studies
- Alaska4 studies
- Arizona12 studies
- Arkansas6 studies
- California68 studies
- Colorado23 studies
- Connecticut11 studies
- Delaware4 studies
- District of Columbia4 studies
- Florida37 studies
- Georgia12 studies
- Idaho3 studies
- Illinois21 studies
- Indiana9 studies
- Iowa9 studies
- Kansas9 studies
- Kentucky9 studies
- Louisiana5 studies
- Maine3 studies
- Maryland20 studies
- Massachusetts34 studies
- Michigan35 studies
- Minnesota17 studies
- Missouri23 studies
- Montana4 studies
- Nebraska9 studies
- Nevada5 studies
- New Jersey13 studies
- New Mexico5 studies
- New York41 studies
- North Carolina22 studies
- North Dakota4 studies
- Ohio23 studies
- Oklahoma11 studies
- Oregon14 studies
- Pennsylvania29 studies
- Rhode Island5 studies
- South Carolina9 studies
- South Dakota4 studies
- Tennessee30 studies
- Texas63 studies
- Utah14 studies
- Virginia29 studies
- Washington14 studies
- West Virginia4 studies
- Wisconsin19 studies
Recently updated studies
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07360314Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
RecruitingObservational study
Ages 2 to 100 · All sexes · Updated Nov 12, 2026 · NCT01950572Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Recruiting
Ages 18 to 99 · All sexes · Updated Nov 12, 2026 · NCT04907643Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis
RecruitingObservational study
Ages 6 and older · All sexes · Updated Nov 9, 2026 · NCT04557969GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric Cancer
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07581405The Vanguard Study: Testing a New Way to Screen for Cancer
RecruitingHealthy volunteers welcome
Ages 45 to 75 · All sexes · Updated Nov 6, 2026 · NCT06995898Avutometinib and Defactinib in Diffuse Gastric Cancer
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT06487221Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT04198766A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RecruitingPhase 1
Ages 19 and older · All sexes · Updated Nov 5, 2026 · NCT06586957A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07221149Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Nov 5, 2026 · NCT06885697cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RecruitingObservational studyHealthy volunteers welcome
Ages 40 and older · All sexes · Updated Nov 4, 2026 · NCT05366881Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Nov 4, 2026 · NCT05334069Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07283939A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07213791A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07114601Distance-Based Exercise to Preserve Function and Prevent Disability
Recruiting
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07059884A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06760819A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06695845A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07578571A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07069712A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07903415Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
RecruitingPhase 1/2
Ages 18 to 72 · All sexes · Updated Nov 3, 2026 · NCT03190941Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT07124351A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT03526835From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.